Immunotherapy and Peptide SequencingIn a healthy person, the immune system can correctly determine the peptides of foreign or irregular cells, such as cancer cells or hazardous bacteria, and then target those cells for damage. To quickly build a profile of the peptides in an unknown cell, researchers have been using a technique called de novo peptide sequencing, which uses mass spectrometry to rapidly analyze a brand-new sample. GraphNovo: A Leap in Sequencing AccuracyUtilizing device learning, GraphNovo significantly boosts the accuracy in recognizing peptide sequences by filling these gaps with the precise mass of the peptide sequence.
Immunotherapy and Peptide SequencingIn a healthy individual, the immune system can correctly recognize the peptides of foreign or irregular cells, such as cancer cells or hazardous bacteria, and then target those cells for damage. To rapidly build a profile of the peptides in an unknown cell, researchers have been utilizing an approach called de novo peptide sequencing, which uses mass spectrometry to rapidly analyze a brand-new sample. GraphNovo: A Leap in Sequencing AccuracyUtilizing machine learning, GraphNovo significantly improves the precision in determining peptide sequences by filling these gaps with the exact mass of the peptide sequence.